Aura Biosciences, Inc. Income Statement

Income Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating items
Research & Development 42.24M65.23M73.30M
Selling, General & Administrative 18.06M19.76M22.81M
Other Operating Expenses -0.32M0.21M
Operating Expenses 60.30M84.99M96.12M
Operating Income -60.30M-84.99M-96.12M
EBIT -60.30M-84.99M-96.12M
Non-operating items
Other Non Operating Income -0.01M-0.08M-0.12M
Non Operating Income 1.53M8.72M9.31M
Net income details
EBT -58.76M-76.27M-86.81M
Tax Provisions 0.14M0.11M
Profit After Tax -58.76M-76.41M-86.92M
Income from Continuing Operations -58.76M-76.41M-86.92M
Consolidated Net Income -58.76M-76.41M-86.92M
Income towards Parent Company -58.76M-76.41M-86.92M
Net Income towards Common Stockholders -58.76M-76.41M-86.92M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 28.01M29.21M29.33M38.26M50.23M
EBITDA -60.30M-75.80M-87.19M